Canadian and Australian scientists develop new method to combat leukemia
A new method for combating leukemia developing Canadian and Australian experts. They were able to create artificial antibodies that destroy the specific protein - C-D-123, part of the membranes cancerous stem cells.
This method may prove to be very promising, since the previous stage of research, this group of scientists has shown that cancerous stem cells are not amenable to chemotherapy. In addition, as reported by researchers in the latest issue of the journal Cell and Stem Cells ", new antibodies do not have a negative impact on" normal "blood cells.
From a Canadian research team led by Senior Research Fellow Cancer Institute, Ontario, John Dick, with an Australian - Adjunct Professor, Institute of Pediatric Oncology Richard Locke. Now, after the pilot phase, scientists are ready to test the effectiveness and safety of a new method in clinics.
Wednesday, March 24, 2010
WHO has endorsed a second vaccine against cervical cancer
WHO has endorsed a second vaccine against cervical cancer
World Health Organization (WHO) approved the drug for a second vaccination against cervical cancer, reports AP. Recommendations to the widespread use of the drug was "Cervarix", produced by GlaxoSmithKline.
This medicine is sold in 97 countries. Approval received from the WHO, indicates that the various UN agencies and charities will be able to begin formal delivery of the drug to vaccinate populations in developing countries.
Charitable Organization World Alliance for Vaccines and Immunization (GAVI) in the last year established a priority in the procurement of drugs for the vaccination of the population 73 poorest countries from cervical cancer. According to company representative Dan Thomas (Dan Thomas), first of all immunizations needed in those countries where the population is unable to undergo early diagnosis of disease.
The first vaccine against cervical cancer, approved by WHO, has become the drug "Gardasil" company Merck. According to representatives of the organization, the use of two drugs will help save tens of thousands of lives.
According to WHO, each year from cervical cancer kills about 280 thousand women. More than 80 percent of them are women living in developing countries.
World Health Organization (WHO) approved the drug for a second vaccination against cervical cancer, reports AP. Recommendations to the widespread use of the drug was "Cervarix", produced by GlaxoSmithKline.
This medicine is sold in 97 countries. Approval received from the WHO, indicates that the various UN agencies and charities will be able to begin formal delivery of the drug to vaccinate populations in developing countries.
Charitable Organization World Alliance for Vaccines and Immunization (GAVI) in the last year established a priority in the procurement of drugs for the vaccination of the population 73 poorest countries from cervical cancer. According to company representative Dan Thomas (Dan Thomas), first of all immunizations needed in those countries where the population is unable to undergo early diagnosis of disease.
The first vaccine against cervical cancer, approved by WHO, has become the drug "Gardasil" company Merck. According to representatives of the organization, the use of two drugs will help save tens of thousands of lives.
According to WHO, each year from cervical cancer kills about 280 thousand women. More than 80 percent of them are women living in developing countries.
Subscribe to:
Posts (Atom)
Posts
